[go: up one dir, main page]

AU2002218494A1 - Medicinal compositions and process for producing the same - Google Patents

Medicinal compositions and process for producing the same

Info

Publication number
AU2002218494A1
AU2002218494A1 AU2002218494A AU1849402A AU2002218494A1 AU 2002218494 A1 AU2002218494 A1 AU 2002218494A1 AU 2002218494 A AU2002218494 A AU 2002218494A AU 1849402 A AU1849402 A AU 1849402A AU 2002218494 A1 AU2002218494 A1 AU 2002218494A1
Authority
AU
Australia
Prior art keywords
producing
same
medicinal compositions
medicinal
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002218494A
Inventor
Yoshio Hata
Yutaka Yamagata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AU2002218494A1 publication Critical patent/AU2002218494A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/02Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002218494A 2000-11-29 2001-11-29 Medicinal compositions and process for producing the same Abandoned AU2002218494A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000362727 2000-11-29
JP2000-362727 2000-11-29
PCT/JP2001/010417 WO2002043766A1 (en) 2000-11-29 2001-11-29 Medicinal compositions and process for producing the same

Publications (1)

Publication Number Publication Date
AU2002218494A1 true AU2002218494A1 (en) 2002-06-11

Family

ID=18833953

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002218494A Abandoned AU2002218494A1 (en) 2000-11-29 2001-11-29 Medicinal compositions and process for producing the same

Country Status (2)

Country Link
AU (1) AU2002218494A1 (en)
WO (1) WO2002043766A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI332407B (en) * 2001-06-29 2010-11-01 Takeda Chemical Industries Ltd Controlled release composition and method of producting the same
EP1479684A4 (en) * 2002-01-30 2006-01-04 Takeda Pharmaceutical THIENOPYRIMIDINES, PROCESS FOR THEIR PRODUCTION AND THEIR USE
SI1591446T1 (en) 2003-01-29 2013-07-31 Takeda Pharmaceutical Company Limited Thienopyrimidine compounds and use thereof
MX2008000820A (en) * 2005-07-22 2008-03-18 Takeda Pharmaceutical Premature ovulation preventive agent.
KR101522035B1 (en) 2006-12-18 2015-05-20 다케다 야쿠힌 고교 가부시키가이샤 Sustained-release composition and method for producing the same
WO2010026993A1 (en) * 2008-09-03 2010-03-11 武田薬品工業株式会社 Method for improving absorbability of preparation, and preparation having improved absorbability

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5195117A (en) * 1975-02-12 1976-08-20 Ridokainno 33 hidorokishi 22 nafutoesanenno seizoho
JPH066534B2 (en) * 1986-10-09 1994-01-26 積水化学工業株式会社 Transdermal patch
CA2062659A1 (en) * 1991-03-12 1992-09-13 Yasutaka Igari Composition for sustained-release of erythropoietin
EP0566135A1 (en) * 1992-04-17 1993-10-20 Takeda Chemical Industries, Ltd. Transmucosal composition comprising a peptide and a cytidine derivative
EP0569096A1 (en) * 1992-05-08 1993-11-10 Akzo Nobel N.V. Depot preparation
TW376319B (en) * 1993-04-28 1999-12-11 Janssen Pharmaceutica Nv Pharmaceutical composition containing risperidone pamoate and having a long acting activity for treating psychoses induced by the release of dopamine
JP3701693B2 (en) * 1993-12-28 2005-10-05 日本製薬株式会社 Sustained release fat emulsion for injection containing analgesics
TW449600B (en) * 1994-04-19 2001-08-11 Takeda Chemical Industries Ltd Condensed-ring thiophene derivatives, their production and use
JPH1045616A (en) * 1996-08-02 1998-02-17 Shionogi & Co Ltd Sustained release preparation for injection
AU5678398A (en) * 1997-01-29 1998-08-18 Takeda Chemical Industries Ltd. Sustained-release microspheres, their production and use
JPH11199521A (en) * 1997-12-26 1999-07-27 Lion Corp External preparation for skin
EP1048301A4 (en) * 1998-01-16 2005-03-09 Takeda Chemical Industries Ltd CONTROLLED RELEASE COMPOSITIONS, PROCESS FOR THEIR MANUFACTURE AND USE
TWI225863B (en) * 1999-03-24 2005-01-01 Takeda Chemical Industries Ltd Thienopyrimidine compounds, their production and use

Also Published As

Publication number Publication date
WO2002043766A1 (en) 2002-06-06

Similar Documents

Publication Publication Date Title
AU6198700A (en) Process for producing phenyl-alkanes compositions produced therefrom, and uses thereof
AU2882201A (en) Sustained-release preparation and process for producing the same
AU2002224082A1 (en) Dimethyl terephthalate composition and process for producing the same
AU2000263163A1 (en) Soft candies and process for producing the same
AU2001280604A1 (en) Compositions comprising icariside i and anhydroicaritin and methods for making the same
AU2001255788A1 (en) Improved endodontic instruments and process for producing the same
AU2001267831A1 (en) DDS compound and process for the preparation thereof
AU2002214324A1 (en) Medicinal compositions
AU2001290239A1 (en) Medicinal composition
AU2002253642A1 (en) Amorphous cefditoren pivoxil composition and process for producing the same
AU2002218494A1 (en) Medicinal compositions and process for producing the same
AU2001252671A1 (en) Pyridobenzodiazine derivatives and processes for the preparation thereof
AU3193200A (en) Tablets and process for producing the same
AU2002229149A1 (en) Process for producing hydrazinomonosaccharide derivatives and use thereof
AU2001260083A1 (en) New pharmaceutical composition and the process for its preparation
AU2401401A (en) Migrastatin, process for producing the same and medicinal compositions
AU2001282541A1 (en) Medicinal compositions
AU2001283030A1 (en) Process for making 3-hydroxyalkanenitriles and hydroxyaminoalkanes
AU5462901A (en) Process for the preparation of (pyridinylidene)-phthalides
AU2001211674A1 (en) Naphthomelanins, process for their preparation and compositions thereof
AU2002216364A1 (en) Novel substance fki-1083 and process for producing the same
AU2000249111A1 (en) New pharmaceutical composition and the process for its preparation
AU2000228300A1 (en) Novel substance fki-0076 and process for producing the same
AU2001227071A1 (en) Novel substance m-17a and process for producing the same
AU4781000A (en) 6-hydroxy-2-naphthylcarbinol and process for the preparation thereof